Trump Administration Injects $150M into xLight
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.XLIGHT STAKE:The Trump administration has agreed to inject up to $150M into xLight, which makes lasers for EUV machines and has former IntelCEO Pat Gelsinger on its board, for an equity stake, The Wall Street Journal's Amrith Ramkumar and Robbie Whelan. ASMLis currently the only global producer of EUV machines, which can cost hundreds of millions of dollars each.AMICABLE SETTLEMENT:Trump Media and Technologyannounced that Trump Media and United Atlantic Ventures reached an "amicable" settlement of their dispute and all claims by Trump Media against United Atlantic Ventures have been mutually resolved.NEW DOD AWARD:Immuronannounced a new research agreement with the Naval Medical Research Command -NMRC - and the Walter Reed Army Institute of Research, or WRAIR, Silver Spring, MD, USA funded by a U.S. Department of Defense subaward.The Naval Medical Research Command and the Walter Reed Army Institute of Research, in collaboration with Immuron, are progressing the development of novel vaccines targeting Campylobacter jejuni and Shigella sonnei. Under a recently executed collaborative research agreement with the Henry M. Jackson Foundation, new vaccine preparations against these pathogens have been developed and formulated at the military research institutes and subsequently provided to Immuron.Immuron will produce two hyper-immune bovine colostrum products for pre-clinical evaluation, with the objective of advancing a combined colostrum-based therapeutic specifically designed for the U.S. military. Also, the Uniformed Services University topline results from its clinical trial evaluating the effectiveness of enterotoxigenic E. coli hyperimmune bovine colostrum in maintaining gut health during deployment and travel are anticipated to be announced at the end of next week. In P2TD study, IMM-124E - the active ingredient in Travelan - was delivered in 600 mg powder sachets and administered twice daily in a randomized, placebo-controlled trial.Infectious diarrhea is the most common illness reported by travelers visiting developing countries and among U.S. troops deployed overseas. In the last decade, several enteric pathogens have an increasing resistance to commonly prescribed antibiotics.
Trade with 70% Backtested Accuracy
Analyst Views on INTC
About INTC
About the author


- AI Demand Boosts CPU Market: With rising AI demand, Intel (INTC) and AMD (AMD) are positioned as key beneficiaries, particularly in the server segment, which is expected to significantly enhance their market performance, although the broader investment narrative has not fully centered around this segment.
- Morgan Stanley's Investment Preference: Morgan Stanley believes that while Intel and AMD play crucial roles in AI-driven CPU demand, they favor U.S. memory stocks, particularly Micron (MU) and Sandisk (SNDK), indicating a more optimistic outlook on memory demand.
- Intel Price Target Increase: Morgan Stanley raised Intel's price target from $41 to $56 and boosted its 2027 EPS estimate from $0.97 to $1.34, surpassing the market consensus of $1.03, reflecting analysts' confidence in its future profitability.
- Earnings Expectations and Stock Performance: Intel is set to report Q1 results on April 23, with expectations of $0.01 EPS on $12.42 billion in revenue, and shares have already climbed over 60% since the last earnings release, indicating growing market optimism about its recovery.
- Massive Investment: Intel is set to invest tens of billions in its manufacturing capabilities, a move that is expected to significantly enhance production efficiency and market competitiveness, ultimately leading to substantial returns for the company.
- Positive Market Reaction: Following the afternoon stock prices on April 16, 2026, Intel's shares rose by 3.90%, indicating investor optimism regarding the company's future growth potential and bolstering market confidence.
- Enhanced Manufacturing Capacity: These investments will enable Intel to expand its semiconductor production capabilities to meet the increasing market demand, particularly in high-performance computing and artificial intelligence, ensuring its leadership position at the forefront of technology.
- Strategic Implications: This investment represents not only an upgrade to existing facilities but also lays the groundwork for Intel's long-term competitiveness in the global semiconductor market, positioning the company favorably in future technological contests.
- Internal Promotion Tradition: John Ternus will become Apple's eighth CEO in September, continuing the company's tradition of promoting from within, which underscores Apple's commitment to nurturing internal talent.
- Rich Experience Background: With 25 years at Apple, Ternus has overseen hardware development for iPads, AirPods, and recent iPhone models, showcasing his pivotal role in product development and indicating a continued focus on innovation.
- AI Strategy Challenge: Upon taking the helm, Ternus will face significant challenges in revamping Apple's lagging AI strategy, particularly with the slow progress of the Siri model, and analysts believe his leadership could reignite optimism in Apple's AI initiatives.
- Leadership Style and Vision: Ternus expressed optimism about the future in his appointment statement, emphasizing that collaboration with Apple's talented team will drive the company's ongoing success in technological innovation and market competitiveness.
- Supply Chain Issues: Intel investors are focusing on the company's efforts to resolve supply chain challenges that have limited its ability to ramp up chip production to meet the rising demand from businesses adopting AI-related services.
- Production Constraints: Intel has warned that supply shortages for its server chips, particularly those used alongside graphics processors from companies like Nvidia, will be most acute in the first quarter, with some easing expected in the second quarter.
- Growing Market Demand: As more businesses adopt AI services, the production challenges faced by Intel could impact its market share, especially in the highly competitive semiconductor industry.
- Need for Strategic Adjustments: To address supply chain bottlenecks, Intel may need to reassess its production strategies to ensure it can meet future market demands and maintain competitiveness.
- Demand-Driven Upgrade: HSBC upgraded Intel's rating from Hold to Buy, emphasizing that the sustained demand for server CPUs is the main driver of the company's growth, with expected server CPU shipments to increase by 20% year-over-year in 2026.
- Price Increase Expectations: In a high-demand and supply-constrained environment, Intel anticipates raising average selling prices, with a projected 20% year-over-year increase in 2026, significantly boosting the company's revenue and gross margins.
- Optimistic Financial Outlook: Analysts expect Intel's revenue for the second quarter to reach $14.2 billion, exceeding Wall Street estimates by 9%, indicating that the company's competitiveness in the market is strengthening.
- Long-Term Growth Potential: The server CPU shortage is expected to extend into 2027, driving a further 20% increase in shipments and a 10% rise in average selling prices, laying a solid foundation for Intel's long-term growth.
- Successful Funding: Syenta recently completed a $26 million Series A funding round led by Playground Global, with former Intel CEO Pat Gelsinger as a general partner, indicating strong market confidence in its advanced packaging technology aimed at commercialization.
- Technological Innovation: The company's Localized Electrochemical Manufacturing technology enables high-density chip-to-chip interconnects within existing semiconductor manufacturing infrastructure, expected to reduce process steps by 40%, thereby accelerating the packaging process for AI systems and alleviating supply chain constraints.
- Strategic Expansion: As part of its commercialization strategy, Syenta is establishing an office in Arizona, located near facilities operated by Intel and TSMC, which will enhance collaboration with major semiconductor manufacturers and further drive market application of its technology.
- Industry Impact: Gelsinger emphasized that Syenta's technology will redefine how high-performance systems are built, particularly as AI workloads continue to grow, addressing fundamental constraints in chip connectivity and potentially reshaping future system construction and scaling.










